glp 1 agonists review GLP-1 receptor are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP-1 Agonists: A Comprehensive Overview
Description
A.HashimotoR.KunugiH.HattoriK.HayakawaK.et al
for library preparation and sequencing using 2 g of RNA per sample
The most frequent adverse effects are gastrointestinal and dose-related: Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort - Typically worst during dose escalation and often resolve or attenuate with continued treatment and slower titration
Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report
Health Serv Outcomes Res Method
Ocular complications have also been reported in some cases
